<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27737" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Scleroderma and Primary Myocardial Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mohameden</surname>
            <given-names>Mosaab</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vashisht</surname>
            <given-names>Priyanka</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharman</surname>
            <given-names>Tariq</given-names>
          </name>
          <aff>Southern Ohio Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mosaab Mohameden declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Priyanka Vashisht declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tariq Sharman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27737.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Systemic scleroderma is a connective tissue disease that can affect internal organs. Cardiac manifestations of the disease can be a result of the primary disease or secondary to the involvement of another organ. Direct involvement can manifest as conduction system abnormalities, myocardial, and pericardial disease. Kidney and lung involvement can lead to hypertensive crisis and pulmonary hypertension (PAH), respectively. Cardiac manifestations can be subclinical, but overall, they portend a poor prognosis. This activity outlines the cardiac manifestations of scleroderma, evaluation, and treatment. It emphasizes the role of the interprofessional team in diagnosing this condition promptly.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the findings of scleroderma and cardiac involvement.</p></list-item><list-item><p>Explain the importance of diagnosing cardiac complications of scleroderma.</p></list-item><list-item><p>Outline the management options available for cardiac complications of scleroderma.</p></list-item><list-item><p>Review the importance of an interprofessional team in improving the quality of life in patients with scleroderma and the importance of continuity of care among the interprofessional team to ensure appropriate follow-up care.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27737&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27737">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27737.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Systemic sclerosis is a rare, complex, and chronic multisystem disease. Scleroderma means hard and thick skin. It is derived from the ancient Greek words "skleros," which means (hard) and "derma," which means (skin). Skin involvement is one of the features of systemic sclerosis (SSc). The hallmark features of systemic sclerosis include immune dysregulation with inflammation, vascular injury with an anatomic and functional abnormality, and systemic interstitial fibrosis of organs and skin, leading to multisystem organ damage.<xref ref-type="bibr" rid="article-27737.r1">[1]</xref>&#x000a0;Cardiac involvement is well recognized in systemic sclerosis, which can affect the pericardium, the myocardium, and the conduction system. Primary cardiac disease is reported in both diffuse and limited systemic sclerosis. However, it was found to be more prevalent and more severe in diffuse systemic sclerosis.<xref ref-type="bibr" rid="article-27737.r2">[2]</xref><xref ref-type="bibr" rid="article-27737.r3">[3]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-27737.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of systemic sclerosis and the exact contributing genetic susceptibility is not fully understood. However, several factors are thought to play a role, and environmental exposure in genetically susceptible individuals is thought to be plausible. Some studies showed that the risk of systemic sclerosis is increased in first-degree relatives; on the other hand, in a twin study, the concordance for systemic sclerosis was found to be relatively low.<xref ref-type="bibr" rid="article-27737.r4">[4]</xref><xref ref-type="bibr" rid="article-27737.r5">[5]</xref>&#x000a0;As with other autoimmune diseases, the major histocompatibility complex (MHC) has been implicated in systemic sclerosis development. Multiple and unique human leukocyte antigens (HLA) class II alleles are associated with systemic sclerosis and specific antibodies profile. For example, HLA DQB1*0301, DRB1*1104, and DQA1*0501 haplotypes were found to be strongly associated with systemic sclerosis.<xref ref-type="bibr" rid="article-27737.r6">[6]</xref>&#x000a0;Also, multiple non-MHC loci have been identified to be associated with systemic sclerosis. These, for example, include IRF5, STAT4, TNIP1, CD247, and PTPN22.<xref ref-type="bibr" rid="article-27737.r7">[7]</xref><xref ref-type="bibr" rid="article-27737.r8">[8]</xref><xref ref-type="bibr" rid="article-27737.r9">[9]</xref><xref ref-type="bibr" rid="article-27737.r10">[10]</xref><xref ref-type="bibr" rid="article-27737.r11">[11]</xref>&#x000a0;</p>
        <p>Some of these non-MHC loci have also been implicated in other autoimmune diseases, such as systemic lupus erythematosus, suggesting that immune dysregulation is a very important factor in systemic sclerosis development.<xref ref-type="bibr" rid="article-27737.r12">[12]</xref>&#x000a0;Epigenetic factors, most notably involving post-translational modification processes, have been described in systemic sclerosis. These are thought to be triggered by environmental factors and commonly involve histone modification, DNA methylation, and changes in non-coding RNAs. The result is thought to be the promotion of profibrotic genes, suppression of antifibrotic molecules, and alteration of fibroblasts function. These changes were also found in some studies to be associated with vasculopathy, fibrosis, B-cell activation, and antibody production.<xref ref-type="bibr" rid="article-27737.r13">[13]</xref><xref ref-type="bibr" rid="article-27737.r14">[14]</xref><xref ref-type="bibr" rid="article-27737.r15">[15]</xref><xref ref-type="bibr" rid="article-27737.r16">[16]</xref><xref ref-type="bibr" rid="article-27737.r17">[17]</xref>&#x000a0;</p>
        <p>Infectious agents, specifically viruses, have been studied and thought to be a factor in SSc development. These include cytomegalovirus (CMV), parvovirus B19, and Epstein-Barr virus (EBV). Several findings and theories have been studied in this regard. These include possible molecular mimicry as some of these viruses contain antigens that were found to share immunogenicity with endothelial peptides. Profibrotic molecules were found to be stimulated by CMV in certain tissues. Also, CMV has been implicated in the allograft vasculopathy, inducing similar vascular pathologic changes as SSc.<xref ref-type="bibr" rid="article-27737.r18">[18]</xref><xref ref-type="bibr" rid="article-27737.r19">[19]</xref><xref ref-type="bibr" rid="article-27737.r20">[20]</xref>&#x000a0;Other environmental factors that are studied in SSc development include exposure to silica dust, occupational organic solvents, polyvinyl chloride, toluene, xylene, trichloroethylene, rapeseed oil, and L-tryptophan.<xref ref-type="bibr" rid="article-27737.r21">[21]</xref><xref ref-type="bibr" rid="article-27737.r22">[22]</xref>&#x000a0;The latter two were associated with SSc-like syndromes, toxic-oil syndrome, and eosinophilia-myalgia syndrome, respectively.<xref ref-type="bibr" rid="article-27737.r23">[23]</xref><xref ref-type="bibr" rid="article-27737.r24">[24]</xref></p>
        <p>Certain drugs have been implicated in SSc such as bleomycin, taxol, pentazocine, and cocaine.<xref ref-type="bibr" rid="article-27737.r25">[25]</xref><xref ref-type="bibr" rid="article-27737.r26">[26]</xref><xref ref-type="bibr" rid="article-27737.r27">[27]</xref> Another potentially plausible finding in some SSc patients is the so-called microchimerism, where persistent fetal cells in the maternal serum are thought to produce immune reaction resulting in SSc.<xref ref-type="bibr" rid="article-27737.r28">[28]</xref><xref ref-type="bibr" rid="article-27737.r29">[29]</xref> However, not all patients with SSc were found to have increased microchimerism. Moreover, microchimerism is thought to have a genetic background where individuals with positive HLA-DQA1*0501 were found to have increased microchimerism regardless of SSc development.<xref ref-type="bibr" rid="article-27737.r30">[30]</xref>&#x000a0;These findings make microchimerism questionable in SSc pathogenesis.&#x000a0;</p>
      </sec>
      <sec id="article-27737.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence and prevalence of SSc vary among different studies. The overall worldwide incidence of SSc is reported to be between 8 to 56 new cases/million/year. Whereas, the overall prevalence is between 38 to 341 cases/million/year. SSc is more common in women (3 to 7: 1 female to male ratio), with an average age of disease onset being 35 to 50. There are several differences in disease presentation between males and females. For instance, females are found to have disease onset at a younger age with longer disease duration. Females are also found to have more limited SSc than men, more frequent but less severe peripheral vascular involvement, and increased frequency of anti-centromere antibodies with pulmonary hypertension being the most frequent cause of mortality.<xref ref-type="bibr" rid="article-27737.r31">[31]</xref></p>
        <p>Primary cardiac disease is reported in both diffuse and limited systemic sclerosis; however, it is more prevalent and more severe in diffuse systemic sclerosis.<xref ref-type="bibr" rid="article-27737.r2">[2]</xref><xref ref-type="bibr" rid="article-27737.r3">[3]</xref>&#x000a0;Several risk factors for cardiac disease in systemic sclerosis have been reported. These include the presence of specific serologies like the anti-U3-RNP antibodies, rapid skin thickness progression, and skeletal muscle involvement.<xref ref-type="bibr" rid="article-27737.r32">[32]</xref><xref ref-type="bibr" rid="article-27737.r33">[33]</xref><xref ref-type="bibr" rid="article-27737.r34">[34]</xref> With the advent of more sensitive cardiac studies, the prevalence of cardiac involvement in SSc is found to be up to 70%, with the majority of cases being subclinical. Clinically overt cardiac involvement is estimated to be around 30%.<xref ref-type="bibr" rid="article-27737.r35">[35]</xref><xref ref-type="bibr" rid="article-27737.r36">[36]</xref><xref ref-type="bibr" rid="article-27737.r37">[37]</xref><xref ref-type="bibr" rid="article-27737.r38">[38]</xref></p>
      </sec>
      <sec id="article-27737.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of cardiac disease in SSc involves repeated abnormal vasoreactivity with coronary microvascular ischemia, reperfusion injury, and myocardial inflammation. Microvascular changes are often seen in the endocardium, whereas lesions suggestive of macrovascular coronary artery disease and atherosclerosis do not appear to be increased in SSc. It appears that microcirculation changes similar to Raynaud changes in peripheral circulation occur in the myocardium. These Recurrent episodes of ischemia and reperfusion often result in contraction band necrosis and replacement fibrosis. The result is an increased myocardial stiffness with reduced compliance. This is thought to be the cause of diastolic dysfunction in SSc, which is known to be associated with increase mortality. The changes in coronary microcirculation are thought to be reversible in early disease, with irreversible structural changes occurring late with disease progression. Acute myocarditis can also occur in SSc and is often reported to be associated with skeletal myositis.<xref ref-type="bibr" rid="article-27737.r35">[35]</xref><xref ref-type="bibr" rid="article-27737.r39">[39]</xref><xref ref-type="bibr" rid="article-27737.r40">[40]</xref><xref ref-type="bibr" rid="article-27737.r41">[41]</xref>&#x000a0;Several extracellular factors and signaling molecules appear to play a role in myocardial injury and fibrosis. These include transforming growth factor-beta, endothelin-1, and oxidative stress via reactive oxygen species.<xref ref-type="bibr" rid="article-27737.r42">[42]</xref>&#x000a0;Systolic dysfunction is reported in SSc but less frequently. It is likely attributable to myocardial inflammation with acute myocarditis being an important risk factor and often associated with skeletal myositis.<xref ref-type="bibr" rid="article-27737.r43">[43]</xref><xref ref-type="bibr" rid="article-27737.r44">[44]</xref></p>
      </sec>
      <sec id="article-27737.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The hallmark pathologic features of SSc include proliferative and/or obliterative vasculopathy with minimal inflammation affecting mainly small vessels with capillary loss and fibrosis.<xref ref-type="bibr" rid="article-27737.r45">[45]</xref>&#x000a0;Myocardial fibrosis in SSc was first described in 1943 by Weiss et al. They reported findings of myocardial scarring not associated with coronary artery disease and recognizing these findings to be unique and specific to SSc. Other frequently reported pathologic findings in the myocardium, including foci of fibrosis distributed throughout the heart. These fibrotic changes are distinct from those related to myocardial infarction in that they tend to involve both ventricles somewhat equally with no correlation to extramural coronary artery distribution.&#x000a0;Moreover, these fibrotic changes tend to extend to the endocardium without sparing subendocardial myocardium, as seen in myocardial infarction. Another consistently reported pathologic findings is the presence of contraction band necrosis with cellular inflammatory response followed by replacement fibrosis.<xref ref-type="bibr" rid="article-27737.r46">[46]</xref></p>
      </sec>
      <sec id="article-27737.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Microvascular coronary artery disease is usually the underlying pathology, with many patients being asymptomatic years before presentation.<xref ref-type="bibr" rid="article-27737.r35">[35]</xref><xref ref-type="bibr" rid="article-27737.r47">[47]</xref>&#x000a0;Some patients may present with anginal chest pain similar to patients with obstructive macrovascular coronary artery disease.<xref ref-type="bibr" rid="article-27737.r48">[48]</xref>&#x000a0;Similarly, many patients with myocardial involvement are found to be asymptomatic, with pathological findings seen on cardiac screening imaging. Those who are symptomatic usually present with heart failure symptoms of fatigue, dyspnea, and signs of volume overload.<xref ref-type="bibr" rid="article-27737.r49">[49]</xref>&#x000a0;Acute myocarditis is also reported in SSc and is usually associated with skeletal myositis and overlap syndrome. This usually presents with acute heart failure symptoms with or without skeletal myopathy symptoms of symmetric proximal muscle weakness and possibly dysphagia.<xref ref-type="bibr" rid="article-27737.r50">[50]</xref>&#x000a0;Heart failure symptoms and signs include dyspnea on exertion or at rest, orthopnea, paroxysmal nocturnal dyspnea, fatigue, weight gain with signs of volume overload including lower extremity edema, positive third heart sound on cardiac auscultation, elevated jugular venous pressure, and hepatojugular reflux. Arrhythmias can also occur with myocardial involvement and usually present with palpitation, presyncope, or syncope.<xref ref-type="bibr" rid="article-27737.r51">[51]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-27737.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation for myocardial disease in scleroderma is very important, given that the majority of patients have no cardiac symptoms early in the course of the disease. Therefore, cardiac screening for asymptomatic patients with SSc has been proposed. This includes obtaining a baseline cardiac clinical evaluation with history and exam, transthoracic echocardiogram, electrocardiogram, lab testing with troponin, and plasma brain natriuretic peptide. Additional testing is indicated in symptomatic patients include cardiac magnetic resonance imaging, stress testing, and/or cardiac catheterization. Referral to a cardiologist is warranted based on the findings of these studies. An interprofessional approach is recommended with the involvement of rheumatologists and cardiologists to provide comprehensive care and recommendations.<xref ref-type="bibr" rid="article-27737.r52">[52]</xref><xref ref-type="bibr" rid="article-27737.r53">[53]</xref></p>
      </sec>
      <sec id="article-27737.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Generally, the management of SSc mostly involves target organ management. Treatment of microvascular coronary artery disease is similar to the general population with optimization of anti-anginal therapy, including antiplatelets, lipid-lowering therapy, nitrates, and calcium channel blockers. Heart failure is generally similar to the general population. Non-selective beta-blockers should generally be considered due to the lower risk of worsening vasoreactivity. Limited data showed some benefits on myocardial function and perfusion with the use of vasodilators such as calcium channel blockers or angiotensin-converting enzyme inhibitors. One study of 601 patients on the use of vasodilators or low dose aspirin suggested potential myocardial preventive benefits in SSc.<xref ref-type="bibr" rid="article-27737.r35">[35]</xref><xref ref-type="bibr" rid="article-27737.r54">[54]</xref>&#x000a0;</p>
        <p>Management of heart failure is not different than the general population. This generally varies based on the type of heart failure, whether diastolic, which is more common with SSc or systolic heart failure. The treatment of diastolic heart failure is mainly with diuretics and blood pressure control. The treatment of systolic heart failure is mainly with beta-blockers, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), diuresis, and the use of inotropes and device therapy in select cases if indicated. Care should be taken to address any underlying medical condition that may predispose to or worsen heart failure or coronary artery diseases such as hypertension, diabetes, and hyperlipidemia. Myocardial inflammation in SSc, whether myocarditis or myopericarditis, was shown to respond to immunosuppression in some studies. However, these data are limited and mostly observational. Several treatments were suggested with reported success, including systemic steroids, cyclophosphamide, mycophenolate, and intravenous immunoglobulin. Normalization of cardiac enzymes with clinical improvement was reported with the use of systemic steroids and cyclophosphamide.<xref ref-type="bibr" rid="article-27737.r43">[43]</xref><xref ref-type="bibr" rid="article-27737.r52">[52]</xref><xref ref-type="bibr" rid="article-27737.r55">[55]</xref><xref ref-type="bibr" rid="article-27737.r56">[56]</xref></p>
      </sec>
      <sec id="article-27737.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several conditions can mimic SSc. These include scleredema, which is characterized by excess mucin deposition presenting with skin thickening and woody induration involving the upper back and posterior portion of the neck. Scleredema is associated with diabetes mellitus, viral infections, and monoclonal gammopathies.<xref ref-type="bibr" rid="article-27737.r57">[57]</xref> Scleromyxedema is another potential mimic of SSc and usually presents with diffuse papular and scleroderma eruptions, mucin deposition, and association with monoclonal gammopathy with the absence of thyroid disease.<xref ref-type="bibr" rid="article-27737.r58">[58]</xref> Eosinophilic fasciitis can also mimic SSc with the collagenous thickening of the subcutaneous fascia.<xref ref-type="bibr" rid="article-27737.r59">[59]</xref>&#x000a0;Finally, morphea is a&#x000a0;relatively benign&#x000a0;inflammatory disorder that causes skin thickening and sclerosis mimicking SSc and should be considered in the differential diagnosis.<xref ref-type="bibr" rid="article-27737.r60">[60]</xref> The myocardial disease appears to be prevalent in patients with SSc even in the absence of symptoms; nonetheless, other causes of myocardial disease should be considered in patients with atypical findings or findings that suggest alternative etiology.<xref ref-type="bibr" rid="article-27737.r61">[61]</xref></p>
      </sec>
      <sec id="article-27737.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Myocardial involvement in SSc carries a poor prognosis. Several studies have shown that a significant number of SSc mortality was related to the presence of cardiac disease, including heart failure and arrhythmias. Cardiac disease was found to be the third leading cause of death in SSc after interstitial lung disease and pulmonary arterial hypertension. In a metanalysis, the hazard ratio of increased mortality was 2.8 (HR = 2.8; 95% CI: 2.1 to 3.8) in patients with cardiac disease.<xref ref-type="bibr" rid="article-27737.r62">[62]</xref><xref ref-type="bibr" rid="article-27737.r63">[63]</xref><xref ref-type="bibr" rid="article-27737.r64">[64]</xref>&#x000a0;These findings highlight the importance of early diagnosis and management of myocardial disease in SSc.</p>
      </sec>
      <sec id="article-27737.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Cardiac involvement in SSc is associated with increased mortality. Several complications can occur with myocardial disease, including heart failure, conduction defects, and tachyarrhythmias.</p>
      </sec>
      <sec id="article-27737.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated on living with scleroderma and educated about signs of cardiac involvement such as new-onset chest pain, shortness of breath, palpitations, weight gain, and fatigue. Patients with heart failure should be warned about symptoms and signs of volume overload.</p>
      </sec>
      <sec id="article-27737.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Scleroderma is a multisystem disease and involves multiple organs. It affects the lives of our patients and their families. The timely diagnosis of this disease and its complications are very important. This population will benefit from an interprofessional team and a care coordinator who can manage their follow-ups.</p>
      </sec>
      <sec id="article-27737.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27737&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27737">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/scleroderma-and-primary-myocardial-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27737">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27737/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27737">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-27737.s16">
        <fig id="article-27737.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pursed Mouth in a Female Patient With Scleroderma. This image shows a female patient with a pursed mouth, indicative of the cutaneous manifestations of scleroderma. Contributed by S Verma, MBBS, DVD, FRCP, FAAD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Pursed__mouth__of__scleroderma__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-27737.s17">
        <title>References</title>
        <ref id="article-27737.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allanore</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Simms</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Distler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Trojanowska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Denton</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Systemic sclerosis.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2015</year>
            <month>Apr</month>
            <day>23</day>
            <volume>1</volume>
            <fpage>15002</fpage>
            <pub-id pub-id-type="pmid">27189141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steen</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Medsger</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.</article-title>
            <source>Arthritis Rheum</source>
            <year>1988</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-203</page-range>
            <pub-id pub-id-type="pmid">3348823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fertig</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rodriguez-Reyna</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Steen</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Medsger</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.</article-title>
            <source>Arthritis Rheum</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>8</issue>
            <fpage>2740</fpage>
            <page-range>2740-6</page-range>
            <pub-id pub-id-type="pmid">17665460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arnett</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moulds</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bias</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Durban</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Paxton</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Weathers</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Reveille</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype.</article-title>
            <source>Arthritis Rheum</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>8</issue>
            <fpage>1362</fpage>
            <page-range>1362-70</page-range>
            <pub-id pub-id-type="pmid">8702445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feghali-Bostwick</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Medsger</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.</article-title>
            <source>Arthritis Rheum</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>7</issue>
            <fpage>1956</fpage>
            <page-range>1956-63</page-range>
            <pub-id pub-id-type="pmid">12847690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arnett</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Gourh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shete</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Honey</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>McNearney</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fischbach</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fritzler</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Mayes</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Reveille</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2010</year>
            <month>May</month>
            <volume>69</volume>
            <issue>5</issue>
            <fpage>822</fpage>
            <page-range>822-7</page-range>
            <pub-id pub-id-type="pmid">19596691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gourh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Assassi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>McNearney</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Fischbach</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arnett</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Mayes</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.</article-title>
            <source>Arthritis Rheum</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>54</volume>
            <issue>12</issue>
            <fpage>3945</fpage>
            <page-range>3945-53</page-range>
            <pub-id pub-id-type="pmid">17133608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radstake</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Gorlova</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rueda</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Alizadeh</surname>
                <given-names>BZ</given-names>
              </name>
              <name>
                <surname>Palomino-Morales</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coenen</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Vonk</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Voskuyl</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Schuerwegh</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Broen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>van Riel</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>van 't Slot</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Italiaander</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ophoff</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Riemekasten</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hunzelmann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Simeon</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Ortego-Centeno</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Gay</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Escribano</surname>
                <given-names>MF</given-names>
              </name>
              <collab>Spanish Scleroderma Group</collab>
              <name>
                <surname>Airo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>van Laar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Herrick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Worthington</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hesselstrand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>de Keyser</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Houssiau</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chee</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Madhok</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shiels</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Westhovens</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kreuter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kiener</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de Baere</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Padykov</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Klareskog</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Beretta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Scorza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lie</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Hoffmann-Vold</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Carreira</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hinchcliff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gregersen</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Ying</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Amos</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Wigley</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Hummers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Assassi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gourh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Koeleman</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Arnett</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mayes</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.</article-title>
            <source>Nat Genet</source>
            <year>2010</year>
            <month>May</month>
            <volume>42</volume>
            <issue>5</issue>
            <fpage>426</fpage>
            <page-range>426-9</page-range>
            <pub-id pub-id-type="pmid">20383147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allanore</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dieud&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Avouac</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Distler</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Amouyel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Matucci-Cerinic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Riemekasten</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Airo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Melchers</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hachulla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cusi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wichmann</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Wipff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Hunzelmann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tiev</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Caramaschi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Diot</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kowal-Bielecka</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Valentini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mouthon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Czirj&#x000e1;k</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Damjanov</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Salvi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller-Ladner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Riccieri</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cracowski</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Letenneur</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dupuy</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Munnich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boileau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis.</article-title>
            <source>PLoS Genet</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>e1002091</fpage>
            <pub-id pub-id-type="pmid">21750679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bossini-Castillo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Broen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Simeon</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Beretta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gorlova</surname>
                <given-names>OY</given-names>
              </name>
              <name>
                <surname>Vonk</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ortego-Centeno</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Espinosa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Carreira</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a de la Pe&#x000f1;a</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Oreiro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rom&#x000e1;n-Ivorra</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Gay</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>S&#x000e1;ez-Comet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Castellv&#x000ed;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Schuerwegh</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Voskuyl</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Hoffmann-Vold</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hesselstrand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nordin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lunardi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scorza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Laar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shiels</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Herrick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Worthington</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Denton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Arnett</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Assassi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koeleman</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Mayes</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Radstake</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>J</given-names>
              </name>
              <collab>Spanish Scleroderma Group</collab>
            </person-group>
            <article-title>Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>602</fpage>
            <page-range>602-7</page-range>
            <pub-id pub-id-type="pmid">22896740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Assassi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diaz-Gallo</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Broen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Simeon</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Castellvi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vicente-Rabaneda</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fonollosa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ortego-Centeno</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Gay</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Espinosa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Carreira</surname>
                <given-names>P</given-names>
              </name>
              <collab>Spanish Scleroderma Group</collab>
              <collab>SLEGEN consortium</collab>
              <collab>U.S. Scleroderma GWAS group</collab>
              <collab>BIOLUPUS</collab>
              <name>
                <surname>Camps</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sabio</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>D'alfonso</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vonk</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Voskuyl</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Schuerwegh</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kreuter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Riemekasten</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hunzelmann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Airo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Beretta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Scorza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lunardi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Van Laar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chee</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Worthington</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Herrick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Denton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Arnett</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Reveille</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Gorlova</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Koeleman</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Radstake</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Vyse</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mayes</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Alarc&#x000f3;n-Riquelme</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci.</article-title>
            <source>Hum Mol Genet</source>
            <year>2013</year>
            <month>Oct</month>
            <day>01</day>
            <volume>22</volume>
            <issue>19</issue>
            <fpage>4021</fpage>
            <page-range>4021-9</page-range>
            <pub-id pub-id-type="pmid">23740937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Assassi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Radstake</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Mayes</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Genetics of scleroderma: implications for personalized medicine?</article-title>
            <source>BMC Med</source>
            <year>2013</year>
            <month>Jan</month>
            <day>11</day>
            <volume>11</volume>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">23311619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dees</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schlottmann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Funke</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Distler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palumbo-Zerr</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zerr</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>NY</given-names>
              </name>
              <name>
                <surname>Beyer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Distler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Schett</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Distler</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>73</volume>
            <issue>6</issue>
            <fpage>1232</fpage>
            <page-range>1232-9</page-range>
            <pub-id pub-id-type="pmid">23698475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Altorok</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsou</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Coit</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khanna</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sawalha</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>74</volume>
            <issue>8</issue>
            <fpage>1612</fpage>
            <page-range>1612-20</page-range>
            <pub-id pub-id-type="pmid">24812288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghosh</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Bhattacharyya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lafyatis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Farina</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thimmapaya</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-&#x003b2;: epigenetic feed-forward amplification of fibrosis.</article-title>
            <source>J Invest Dermatol</source>
            <year>2013</year>
            <month>May</month>
            <volume>133</volume>
            <issue>5</issue>
            <fpage>1302</fpage>
            <page-range>1302-10</page-range>
            <pub-id pub-id-type="pmid">23303459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Asano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taniguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fujiu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Manabe</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saigusa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Akamata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ichimura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Toyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuruta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Trojanowska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.</article-title>
            <source>Nat Commun</source>
            <year>2014</year>
            <month>Dec</month>
            <day>12</day>
            <volume>5</volume>
            <fpage>5797</fpage>
            <pub-id pub-id-type="pmid">25504335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>XH</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>RZ</given-names>
              </name>
              <name>
                <surname>Shu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kanekura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>QJ</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis.</article-title>
            <source>Br J Dermatol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>171</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-47</page-range>
            <pub-id pub-id-type="pmid">24641670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muryoi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kasturi</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Kafina</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cram</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bona</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes.</article-title>
            <source>J Exp Med</source>
            <year>1992</year>
            <month>Apr</month>
            <day>01</day>
            <volume>175</volume>
            <issue>4</issue>
            <fpage>1103</fpage>
            <page-range>1103-9</page-range>
            <pub-id pub-id-type="pmid">1372644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lunardi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bason</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Navone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Millo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Damonte</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corrocher</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Puccetti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.</article-title>
            <source>Nat Med</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>6</volume>
            <issue>10</issue>
            <fpage>1183</fpage>
            <page-range>1183-6</page-range>
            <pub-id pub-id-type="pmid">11017152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markiewicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Rubinchik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Trojanowska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>LeRoy</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2004</year>
            <season>Jan-Feb</season>
            <volume>22</volume>
            <issue>3 Suppl 33</issue>
            <fpage>S31</fpage>
            <page-range>S31-4</page-range>
            <pub-id pub-id-type="pmid">15344595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCormic</surname>
                <given-names>ZD</given-names>
              </name>
              <name>
                <surname>Khuder</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Aryal</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Ames</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Khuder</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Occupational silica exposure as a risk factor for scleroderma: a meta-analysis.</article-title>
            <source>Int Arch Occup Environ Health</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>83</volume>
            <issue>7</issue>
            <fpage>763</fpage>
            <page-range>763-9</page-range>
            <pub-id pub-id-type="pmid">20047060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nietert</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Sutherland</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Hoel</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Dosemeci</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Is occupational organic solvent exposure a risk factor for scleroderma?</article-title>
            <source>Arthritis Rheum</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>1111</fpage>
            <page-range>1111-8</page-range>
            <pub-id pub-id-type="pmid">9627022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tabuenca</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.</article-title>
            <source>Lancet</source>
            <year>1981</year>
            <month>Sep</month>
            <day>12</day>
            <volume>2</volume>
            <issue>8246</issue>
            <fpage>567</fpage>
            <page-range>567-8</page-range>
            <pub-id pub-id-type="pmid">6116011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hertzman</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Blevins</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Greenfield</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.</article-title>
            <source>N Engl J Med</source>
            <year>1990</year>
            <month>Mar</month>
            <day>29</day>
            <volume>322</volume>
            <issue>13</issue>
            <fpage>869</fpage>
            <page-range>869-73</page-range>
            <pub-id pub-id-type="pmid">2314421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finch</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Rodnan</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Buckingham</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Prince</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Winkelstein</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Bleomycin-induced scleroderma.</article-title>
            <source>J Rheumatol</source>
            <year>1980</year>
            <season>Sep-Oct</season>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>651</fpage>
            <page-range>651-9</page-range>
            <pub-id pub-id-type="pmid">6160247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>In perspective: murine models of scleroderma.</article-title>
            <source>Curr Rheumatol Rep</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-82</page-range>
            <pub-id pub-id-type="pmid">18638424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Angelis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bugatti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cerioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Del Medico</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Filosa</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer.</article-title>
            <source>Clin Rheumatol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-52</page-range>
            <pub-id pub-id-type="pmid">12605319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Furst</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>McSweeney</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Zhen</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Bianchi</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis.</article-title>
            <source>Arthritis Rheum</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>44</volume>
            <issue>8</issue>
            <fpage>1848</fpage>
            <page-range>1848-54</page-range>
            <pub-id pub-id-type="pmid">11508438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Artlett</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Welsh</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis.</article-title>
            <source>Immunogenetics</source>
            <year>1997</year>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-22</page-range>
            <pub-id pub-id-type="pmid">9382916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lambert</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Hashizumi</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Maloney</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gooley</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Furst</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity.</article-title>
            <source>J Immunol</source>
            <year>2000</year>
            <month>Jun</month>
            <day>01</day>
            <volume>164</volume>
            <issue>11</issue>
            <fpage>5545</fpage>
            <page-range>5545-8</page-range>
            <pub-id pub-id-type="pmid">10820227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peoples</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Medsger</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosario</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Feghali-Bostwick</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes.</article-title>
            <source>J Scleroderma Relat Disord</source>
            <year>2016</year>
            <season>May-Aug</season>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-240</page-range>
            <pub-id pub-id-type="pmid">29242839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steen</surname>
                <given-names>VD</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies in systemic sclerosis.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">16084222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nihtyanova</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Denton</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies as predictive tools in systemic sclerosis.</article-title>
            <source>Nat Rev Rheumatol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>112</fpage>
            <page-range>112-6</page-range>
            <pub-id pub-id-type="pmid">20125179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ranque</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Authier</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Berezne</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guillevin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mouthon</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Systemic sclerosis-associated myopathy.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>1108</volume>
            <fpage>268</fpage>
            <page-range>268-82</page-range>
            <pub-id pub-id-type="pmid">17899625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kahan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Allanore</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Primary myocardial involvement in systemic sclerosis.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>45 Suppl 4</volume>
            <fpage>iv14</fpage>
            <page-range>iv14-7</page-range>
            <pub-id pub-id-type="pmid">16980717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parks</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Parks</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Systemic sclerosis and the heart.</article-title>
            <source>Rheum Dis Clin North Am</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-102</page-range>
            <pub-id pub-id-type="pmid">24268011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desai</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Systemic sclerosis and the heart: current diagnosis and management.</article-title>
            <source>Curr Opin Rheumatol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>545</fpage>
            <page-range>545-54</page-range>
            <pub-id pub-id-type="pmid">21897256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tyndall</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Bannert</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vonk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Air&#x000f2;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cozzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Carreira</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Bancel</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Allanore</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller-Ladner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Distler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Iannone</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pellerito</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pileckyte</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miniati</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ananieva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gurman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Damjanov</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valentini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Riemekasten</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tikly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hummers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Henriques</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Caramaschi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Scheja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rozman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ton</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kum&#x000e1;novics</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coleiro</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Feierl</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Szucs</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Von M&#x000fc;hlen</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Riccieri</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Novak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chizzolini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kotulska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Denton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Coelho</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>K&#x000f6;tter</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Simsek</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>de la Pena Lefebvre</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Hachulla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Seibold</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Rednic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stork</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morovic-Vergles</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>UA</given-names>
              </name>
            </person-group>
            <article-title>Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>69</volume>
            <issue>10</issue>
            <fpage>1809</fpage>
            <page-range>1809-15</page-range>
            <pub-id pub-id-type="pmid">20551155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allanore</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Meune</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2010</year>
            <season>Sep-Oct</season>
            <volume>28</volume>
            <issue>5 Suppl 62</issue>
            <fpage>S48</fpage>
            <page-range>S48-53</page-range>
            <pub-id pub-id-type="pmid">21050545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hinchcliff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2012</year>
            <season>Mar-Apr</season>
            <volume>30</volume>
            <issue>2 Suppl 71</issue>
            <fpage>S30</fpage>
            <page-range>S30-7</page-range>
            <pub-id pub-id-type="pmid">22338601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Follansbee</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Zerbe</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Medsger</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association.</article-title>
            <source>Am Heart J</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>125</volume>
            <issue>1</issue>
            <fpage>194</fpage>
            <page-range>194-203</page-range>
            <pub-id pub-id-type="pmid">8417518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ayers</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>Transforming growth factor-&#x003b2; signaling in systemic sclerosis.</article-title>
            <source>J Biomed Res</source>
            <year>2018</year>
            <month>Jan</month>
            <day>18</day>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-12</page-range>
            <pub-id pub-id-type="pmid">29353817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pieroni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Santis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zizzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bosello</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smaldone</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Campioni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Luca</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Laria</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meduri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bellocci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bonomo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Crea</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ferraccioli</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>526</fpage>
            <page-range>526-35</page-range>
            <pub-id pub-id-type="pmid">23932313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>West</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Killian</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Lawless</surname>
                <given-names>OJ</given-names>
              </name>
            </person-group>
            <article-title>Association of myositis and myocarditis in progressive systemic sclerosis.</article-title>
            <source>Arthritis Rheum</source>
            <year>1981</year>
            <month>May</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>662</fpage>
            <page-range>662-8</page-range>
            <pub-id pub-id-type="pmid">7236323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Angelo</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Fries</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Masi</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Shulman</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.</article-title>
            <source>Am J Med</source>
            <year>1969</year>
            <month>Mar</month>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>428</fpage>
            <page-range>428-40</page-range>
            <pub-id pub-id-type="pmid">5780367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bulkley</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Ridolfi</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Salyer</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Hutchins</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.</article-title>
            <source>Circulation</source>
            <year>1976</year>
            <month>Mar</month>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>483</fpage>
            <page-range>483-90</page-range>
            <pub-id pub-id-type="pmid">1248080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faccini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agricola</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Oppizzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Margonato</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Galderisi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sabbadini</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Franchini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Camici</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Coronary microvascular dysfunction in asymptomatic patients affected by systemic sclerosis - limited vs. diffuse form.</article-title>
            <source>Circ J</source>
            <year>2015</year>
            <volume>79</volume>
            <issue>4</issue>
            <fpage>825</fpage>
            <page-range>825-9</page-range>
            <pub-id pub-id-type="pmid">25740209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexander</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Firestein</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Heuser</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Leitl</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Brinker</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ciuffo</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.</article-title>
            <source>Ann Intern Med</source>
            <year>1986</year>
            <month>Nov</month>
            <volume>105</volume>
            <issue>5</issue>
            <fpage>661</fpage>
            <page-range>661-8</page-range>
            <pub-id pub-id-type="pmid">3767147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mavrogeni</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Bratis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Karabela</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Spiliotis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wijk</surname>
                <given-names>Kv</given-names>
              </name>
              <name>
                <surname>Hautemann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reiber</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Koutsogeorgopoulou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Markousis-Mavrogenis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kolovou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Stavropoulos</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis.</article-title>
            <source>Inflamm Allergy Drug Targets</source>
            <year>2015</year>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-36</page-range>
            <pub-id pub-id-type="pmid">26374223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paik</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Wigley</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Mejia</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Hummers</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma.</article-title>
            <source>Arthritis Care Res (Hoboken)</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>68</volume>
            <issue>11</issue>
            <fpage>1695</fpage>
            <page-range>1695-1703</page-range>
            <pub-id pub-id-type="pmid">26881982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed.</article-title>
            <source>Circ Heart Fail</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>8</issue>
            <fpage>e002922</fpage>
            <pub-id pub-id-type="pmid">27436837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bissell</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burgess</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chakravarty</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Coghlan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dumitru</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pauling</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Plein</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schlosshan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Woolfson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Buch</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2017</year>
            <month>Jun</month>
            <day>01</day>
            <volume>56</volume>
            <issue>6</issue>
            <fpage>912</fpage>
            <page-range>912-921</page-range>
            <pub-id pub-id-type="pmid">28160468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Avouac</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fransen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>UA</given-names>
              </name>
              <name>
                <surname>Riccieri</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Miniati</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tarner</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Randone</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Cutolo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Allanore</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Distler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Valentini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Czirjak</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller-Ladner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Furst</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Tyndall</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matucci-Cerinic</surname>
                <given-names>M</given-names>
              </name>
              <collab>EUSTAR Group</collab>
            </person-group>
            <article-title>Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>70</volume>
            <issue>3</issue>
            <fpage>476</fpage>
            <page-range>476-81</page-range>
            <pub-id pub-id-type="pmid">21081523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valentini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Huscher</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Riccardi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fasano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Irace</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Messiniti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Matucci-Cerinic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guiducci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Distler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Avouac</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tarner</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Frerix</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Riemekasten</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Siegert</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Czirj&#x000e1;k</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>L&#x000f3;r&#x000e1;nd</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Denton</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Nihtyanova</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>UA</given-names>
              </name>
              <name>
                <surname>Jaeger</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Del Galdo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abignano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ananieva</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Gherghe</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mihai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Henes</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Schmeiser</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vacca</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moiseev</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Foeldvari</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gabrielli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krummel-Lorenz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rednic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Allanore</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>M&#x000fc;eller-Ladner</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>78</volume>
            <issue>11</issue>
            <fpage>1576</fpage>
            <page-range>1576-1582</page-range>
            <pub-id pub-id-type="pmid">31391176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winter</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Sulzgruber</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Koller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bartko</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Goliasch</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Niessner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis.</article-title>
            <source>Heart Fail Rev</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>573</fpage>
            <page-range>573-581</page-range>
            <pub-id pub-id-type="pmid">29862463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stack</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McLaughlin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sinnot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>MacEneaney</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Eltahir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harney</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone.</article-title>
            <source>Scand J Rheumatol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>349</fpage>
            <page-range>349-50</page-range>
            <pub-id pub-id-type="pmid">20476869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beers</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Ince</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Scleredema adultorum of Buschke: a case report and review of the literature.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>355</fpage>
            <page-range>355-9</page-range>
            <pub-id pub-id-type="pmid">16765712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rongioletti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rebora</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>273</fpage>
            <page-range>273-81</page-range>
            <pub-id pub-id-type="pmid">11174386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shulman</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Diffuse fasciitis with eosinophilia: a new syndrome?</article-title>
            <source>Trans Assoc Am Physicians</source>
            <year>1975</year>
            <volume>88</volume>
            <fpage>70</fpage>
            <page-range>70-86</page-range>
            <pub-id pub-id-type="pmid">1224441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sehgal</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Behl</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Choudhary</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bajaj</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Localized scleroderma/morphea.</article-title>
            <source>Int J Dermatol</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>41</volume>
            <issue>8</issue>
            <fpage>467</fpage>
            <page-range>467-75</page-range>
            <pub-id pub-id-type="pmid">12207760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Candell-Riera</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Armadans-Gil</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sime&#x000f3;n</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Castell-Conesa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fonollosa-Pla</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-del-Castillo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vaqu&#x000e9;-Rafart</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vilardell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soler-Soler</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis.</article-title>
            <source>Arthritis Rheum</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>1138</fpage>
            <page-range>1138-45</page-range>
            <pub-id pub-id-type="pmid">8670322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ioannidis</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Vlachoyiannopoulos</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Haidich</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Medsger</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Michet</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Kuwana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yasuoka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>van den Hoogen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Te Boome</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>van Laar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Verbeet</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Matucci-Cerinic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Georgountzos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moutsopoulos</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Mortality in systemic sclerosis: an international meta-analysis of individual patient data.</article-title>
            <source>Am J Med</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>118</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-10</page-range>
            <pub-id pub-id-type="pmid">15639201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Dhaher</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ouimet</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Determinants of morbidity and mortality of systemic sclerosis in Canada.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>269</fpage>
            <page-range>269-77</page-range>
            <pub-id pub-id-type="pmid">18706680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27737.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czirj&#x000e1;k</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kum&#x000e1;novics</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Varj&#x000fa;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nagy</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>P&#x000e1;kozdi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Szekanecz</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Szucs</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Survival and causes of death in 366 Hungarian patients with systemic sclerosis.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-63</page-range>
            <pub-id pub-id-type="pmid">17519276</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
